Oct 2020: All 13 participating hospital departments of CLEO study are in intervention phase!
1 okt 2020
13 hospital departments of 3 countries participate in CLEO (Clinical Evaluation of DeltaScan). CLEO has a stepped wedge design, so some departments had a short control phase and a long intervention phase and others the opposite. Since 1 October 2020 all participants are in the control phase, meaning that DeltaScan is used for detection and monitoring for delirium.
This milestone was “celebrated” with an attractively designed 2-page CLEO newsletter, that was sent to all participants. The German centers received it in German language, the Dutch and Belgian centers in Dutch.
Back to all news items
3584 CH Utrecht
tel: +31 (0)6 2297 8972